Literature DB >> 26554439

Restless-legs syndrome and insomnia in hemodialysis patients.

Demet Yildiz1, Serdar Kahvecioğlu2, Nilufer Buyukkoyuncu1, Ahmat Kasım Kilic1, Abdulmecit Yildiz3, Cuma Bulent Gul2, Meral Seferoglu4, Fatih Tufan5.   

Abstract

AIM/
BACKGROUND: Restless legs syndrome (RLS) is a common neurological movement disorder which is commonly seen in hemodialysis (HD) patients. Insomnia, depression, and anxiety disorders frequently show concurrence. In this study, we aimed to investigate RLS and insomnia prevalence and related factors in HD patients. SUBJECTS AND METHODS: Patients who were under HD treatment and healthy controls with similar mean age, sex ratio, and hypertension and diabetes mellitus frequency were included in this study. Depression, insomnia, and daytime sleepiness assessments were performed by using Beck Depression Inventory, Insomnia Severity Index, and Epworth Sleepiness Scale. The diagnosis of RLS was made using the International RLS Study Group consensus criteria.
RESULTS: About 156 HD patients and 35 controls were enrolled. The mean age was 50.6 in the HD group and 49.7 in the control group. Female sex was 43.9% in the HD group and 57.1% in the control group. RLS was significantly more frequent in HD patients compared with controls. The rate of sub-threshold insomnia and insomnia with moderate severity was higher in HD patients. While insomnia severity score and diabetes mellitus were significantly associated with the presence of RLS, depression, RLS, older age, and being under HD treatment were independently associated with insomnia severity.
CONCLUSIONS: HD patients commonly have RLS and insomnia. Insomnia and diabetes mellitus seem to be major factors underlying RLS in HD patients. Furthermore, depression and RLS seem to be closely related to insomnia in these patients. Treatment of depression, insomnia, and RLS may be beneficial to improve quality of life in HD patients.

Entities:  

Keywords:  Anxiety; depression; hemodialysis; insomnia; restless legs syndrome

Mesh:

Year:  2015        PMID: 26554439     DOI: 10.3109/0886022X.2015.1111118

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  5 in total

1.  Risk factors of primary and secondary restless legs syndrome among a middle-aged population in Saudi Arabia: A community-based study.

Authors:  Samah Alsafadi; Bahaa Abaalkhail; Siraj Omar Wali; Khaled Aljammali; Bedor Alotaiby; Ibrahim Zakaria; Hanadi Sabbahi
Journal:  Ann Thorac Med       Date:  2018 Jul-Sep       Impact factor: 2.219

2.  Rotigotine suppresses sleep-related muscle activity augmented by injection of dialysis patients' sera in a mouse model of restless legs syndrome.

Authors:  Kazuhiro Muramatsu; Sachiko Chikahisa; Noriyuki Shimizu; Hiroyoshi Séi; Yuichi Inoue
Journal:  Sci Rep       Date:  2019-11-08       Impact factor: 4.379

3.  Prevalence of restless legs syndrome in people with diabetes mellitus: A pooling analysis of observational studies.

Authors:  Pingping Ning; Xin Mu; Xinglong Yang; Tian Li; Yanming Xu
Journal:  EClinicalMedicine       Date:  2022-03-24

4.  Severe restless legs syndrome in a family with Alport syndrome.

Authors:  Davide Sparasci; Andrea Rossinelli; Raffaele Ferri; Pietro Cippà; Andrea Rinaldi; Mauro Manconi
Journal:  BMC Nephrol       Date:  2021-07-05       Impact factor: 2.388

5.  Insomnia in patients on hemodialysis for a short versus long duration.

Authors:  Tetsu Tomita; Norio Yasui-Furukori; Masaki Oka; Takaaki Shimizu; Aya Nagashima; Kento Mitsuhashi; Hisao Saito; Kazuhiko Nakamura
Journal:  Neuropsychiatr Dis Treat       Date:  2016-09-02       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.